Filter Results:
(5,139)
Show Results For
- All HBS Web
(17,629)
- Faculty Publications (5,139)
Show Results For
- All HBS Web
(17,629)
- Faculty Publications (5,139)
- 2024
- Working Paper
Igniting Innovation: Evidence from PyTorch on Technology Control in Open Collaboration
By: Daniel Yue and Frank Nagle
Many companies offer free access to their technology to encourage outside addon
innovation, hoping to later profit by raising prices or harnessing the power of the crowd
while continuing to steer the direction of innovation. They can achieve this balance by
opening... View Details
Keywords: Technological Innovation; Power and Influence; Collaborative Innovation and Invention; Corporate Governance
Yue, Daniel, and Frank Nagle. "Igniting Innovation: Evidence from PyTorch on Technology Control in Open Collaboration." Harvard Business School Working Paper, No. 25-013, September 2024.
- September 2024
- Case
Google Quantum AI
By: David B. Yoffie, Michael A. Cusumano and Matt Higgins
Quantum computing may be the most important nascent computing technology of the 21st century. It has the potential to impact industries ranging from drug discovery to cybersecurity. Google's Quantum AI is one of the leaders in quantum research. This case explores... View Details
Keywords: Business Model; Price; Technological Innovation; Resource Allocation; Business Strategy; Information Technology Industry
Yoffie, David B., Michael A. Cusumano, and Matt Higgins. "Google Quantum AI." Harvard Business School Case 725-362, September 2024.
- September 12, 2024
- Other Article
Review of Widy Novantyo Susanto, "U.S.-Japanese Relations, ASEAN, and Economic Power in Southeast Asia, 1969–1981," April 2024
By: Mattias Fibiger
Fibiger, Mattias. Review of Widy Novantyo Susanto, "U.S.-Japanese Relations, ASEAN, and Economic Power in Southeast Asia, 1969–1981," April 2024. Article Review 1217. H-Diplo (September 12, 2024).
- September 2024
- Case
Myeloma Investment Fund
By: Kyle Myers and Scott Sawaya
This case explores a critical decision facing the Myeloma Investment Fund (MIF) as it evaluates two investment opportunities aimed at accelerating a cure for multiple myeloma.
The MIF, a venture philanthropy fund, must choose between two distinct paths. One... View Details
The MIF, a venture philanthropy fund, must choose between two distinct paths. One... View Details
Keywords: Venture Philanthropy; Biomedical Research; Investing For Impact; Innovation & Entrepreneurship; Venture Capital; Science-Based Business; Philanthropy and Charitable Giving; Decision Making; Health Care and Treatment; Biotechnology Industry; Pharmaceutical Industry
Myers, Kyle, and Scott Sawaya. "Myeloma Investment Fund." Harvard Business School Case 625-047, September 2024.
- September 2024 (Revised October 2024)
- Case
River Remedy: Navigating Mississippi’s Medical Marijuana Market
By: Robin Greenwood, Richard S. Ruback and Robert Ialenti
MBA student William Chism, the founder of a fully integrated medical marijuana company based in Mississippi, must respond to a significant disruption in the fledgling industry. In late 2023, Rapid Analytics, one of two active licensed testing facilities, has its... View Details
Keywords: Plant-Based Agribusiness; Business Growth and Maturation; Forecasting and Prediction; Microeconomics; Local Range; Government Legislation; Demand and Consumers; Supply and Industry; Competitive Strategy; Governance Controls; Agriculture and Agribusiness Industry; Consumer Products Industry; Mississippi
Greenwood, Robin, Richard S. Ruback, and Robert Ialenti. "River Remedy: Navigating Mississippi’s Medical Marijuana Market." Harvard Business School Case 225-011, September 2024. (Revised October 2024.)
- September 2024 (Revised October 2024)
- Case
Anker Innovations (A)
By: Feng Zhu, Jiangyong Lu and Nancy Hua Dai
An Amazon-native brand, Anker is the world’s No. 1 mobile charging brand and a leading consumer electronics company. Over the years, Anker developed an effective model of proving new products online first by leveraging customer insights from its proprietary Voice of... View Details
Keywords: Decision Choices and Conditions; Product; Distribution; Product Launch; Electronics Industry; Consumer Products Industry
Zhu, Feng, Jiangyong Lu, and Nancy Hua Dai. "Anker Innovations (A)." Harvard Business School Case 625-057, September 2024. (Revised October 2024.)
- September 2024
- Supplement
Anker Innovations (B)
By: Feng Zhu, Jiangyong Lu and Nancy Hua Dai
An Amazon-native brand, Anker is the world’s No. 1 mobile charging brand and a leading consumer electronics company. Over the years, Anker developed an effective model of proving new products online first by leveraging customer insights from its proprietary Voice of... View Details
Keywords: Decision Choices and Conditions; Product; Distribution; Product Launch; Business Model; Electronics Industry; Consumer Products Industry
Zhu, Feng, Jiangyong Lu, and Nancy Hua Dai. "Anker Innovations (B)." Harvard Business School Supplement 625-058, September 2024.
- September 9, 2024
- Article
Ten Questions for a Winning Climate-transition Business Strategy
By: George Serafeim
The move to a low-carbon economy will create opportunities for innovation and growth. To make the most of them, leaders must understand the challenges they could face along the way. View Details
Keywords: Technology; Organizational Transformations; Business Model Innovation; Innovation and Invention; Climate Change; Transformation; Leadership; Business Strategy; Environmental Sustainability; Change Management; Entrepreneurship
Serafeim, George. "Ten Questions for a Winning Climate-transition Business Strategy." Strategy + Business (website) (September 9, 2024).
- September 2024 (Revised March 2025)
- Case
Burn the Gondolas? Venice, the Ghetto, and the Seasons of Capitalism
By: Sophus A. Reinert, Charlotte Robertson and Robert Fredona
This case uses the history of Venice—from the driving of the first pylons in the lagoon to the abdication of the city’s last doge, across the ages of Marco Polo and Vivaldi—to explore the invention and global diffusion of capitalism, as well as the cyclical rise and... View Details
Reinert, Sophus A., Charlotte Robertson, and Robert Fredona. "Burn the Gondolas? Venice, the Ghetto, and the Seasons of Capitalism." Harvard Business School Case 725-006, September 2024. (Revised March 2025.)
- September 2024
- Case
Nvidia, Inc. in 2024 and the Future of AI
By: David B. Yoffie and Sarah von Bargen
Nvidia was one of the most successful companies in the world, reaching $3.4 trillion in valuation on June 18th, 2024. While Microsoft and Apple quickly recaptured the value crown, some analysts forecasted that Nvidia was so strongly positioned that it might become the... View Details
Keywords: Customer Value and Value Chain; Price; Technological Innovation; Competition; Vertical Integration; Valuation; Technology Industry
Yoffie, David B., and Sarah von Bargen. "Nvidia, Inc. in 2024 and the Future of AI." Harvard Business School Case 725-360, September 2024.
- 2025
- Working Paper
Markups and Cost Pass-through Along the Supply Chain
By: Santiago Alvarez-Blaser, Alberto Cavallo, Alexander MacKay and Paolo Mengano
We study markups and pricing strategies along the supply chain. Our unique dataset combines detailed price and cost information from a large global manufacturer with matched retail prices collected online for the period July 2018 through June 2023. We show that total... View Details
Alvarez-Blaser, Santiago, Alberto Cavallo, Alexander MacKay, and Paolo Mengano. "Markups and Cost Pass-through Along the Supply Chain." Harvard Business School Working Paper, No. 25-009, August 2024. (Revised February 2025.)
- 2024
- Working Paper
Does Private Equity Have Any Business Being in the Health Care Business?
By: Nori Gerardo Lietz and Zirui Song
Private Equity (“PE”) has come under increased scrutiny by the press, academics, and policymakers, as well as the public, for its investments in health care delivery. This scrutiny has been exacerbated by recent high profile hospital bankruptcies following PE... View Details
Lietz, Nori Gerardo, and Zirui Song. "Does Private Equity Have Any Business Being in the Health Care Business?" Harvard Business School Working Paper, No. 25-012, September 2024.
- 2024
- Working Paper
Behavioral Attenuation
By: Thomas Graeber, Benjamin Enke, Ryan Oprea and Jeffrey Yang
We report a large-scale examination of behavioral attenuation: due to information-processing constraints, the elasticity of people’s decisions with respect to economic fundamentals is generally too small. We implement more than 30 experiments, 20 of which were... View Details
Graeber, Thomas, Benjamin Enke, Ryan Oprea, and Jeffrey Yang. "Behavioral Attenuation." NBER Working Paper Series, No. 32973, September 2024.
- September 2024
- Article
Gender Gaps: Back and Here to Stay? Evidence from Skilled Ugandan Workers During COVID-19
By: Livia Alfonsi, Mary Namubiru and Sara Spaziani
We investigate gender disparities in the effect of COVID-19 on the labor market outcomes of skilled Ugandan workers. Leveraging a high-frequency panel dataset, we find that the lockdowns imposed in Uganda reduced employment by 69% for women and by 45% for men,... View Details
Alfonsi, Livia, Mary Namubiru, and Sara Spaziani. "Gender Gaps: Back and Here to Stay? Evidence from Skilled Ugandan Workers During COVID-19." Review of Economics of the Household 22, no. 3 (September 2024): 999–1046.
- 2024
- Working Paper
Patent Hunters
By: Lauren Cohen, Umit Gurun, Katie Moon and Paula Suh
Analyzing millions of patents granted by the USPTO between 1976 and 2020, we find a pattern where specific patents only rise to prominence after considerable time has passed. Amongst these late-blooming influential patents, we show that there are key players (patent... View Details
Cohen, Lauren, Umit Gurun, Katie Moon, and Paula Suh. "Patent Hunters." NBER Working Paper Series, No. 32965, September 2024.
- September 2024
- Article
Standing on the Shoulders of Science
By: Joshua Lev Krieger, Monika Schnitzer and Martin Watzinger
Today’s innovations rely on scientific discoveries of the past, yet only some corporate
R&D builds directly on scientific output. In this paper, we analyze U.S. patents to
investigate how firms generate value by building on prior art “closer” to science. We
show... View Details
Krieger, Joshua Lev, Monika Schnitzer, and Martin Watzinger. "Standing on the Shoulders of Science." Strategic Management Journal 45, no. 9 (September 2024): 1670–1695.
- September 2024
- Article
The Human Side of the Future of Work: Understanding the Role People Play in Shaping a Changing World
By: Jochen I. Menges, Lauren C. Howe, Erika Hall, Jon M. Jachimowicz, Sharon K. Parker, Riki Takeuchi, Abhijeet K. Vadera, Ashley Whillans and Susan K. Cohen
For as long as there has been work, there has been a “future of work,” through humans’ ingenuity and drive to get things done easier, faster, and better. With the industrial revolution, efforts to shape a better future of work were dominated by improvements in... View Details
Menges, Jochen I., Lauren C. Howe, Erika Hall, Jon M. Jachimowicz, Sharon K. Parker, Riki Takeuchi, Abhijeet K. Vadera, Ashley Whillans, and Susan K. Cohen. "The Human Side of the Future of Work: Understanding the Role People Play in Shaping a Changing World." Academy of Management Discoveries 10, no. 3 (September 2024): 307–318.
- 2024
- Working Paper
Voting Rules, Turnout, and Economic Policies
By: Enrico Cantoni, Vincent Pons and Jérôme Schäfer
In recent years, voter ID laws and convenience voting have generated heated partisan debates. To shed light on these policy issues, we survey the recent evidence on the institutional determinants and effects of voter turnout and broaden the perspective beyond the most... View Details
Cantoni, Enrico, Vincent Pons, and Jérôme Schäfer. "Voting Rules, Turnout, and Economic Policies." NBER Working Paper Series, No. 32941, September 2024.
- August 2024 (Revised February 2025)
- Case
Novo Nordisk Foundation
By: Debora L. Spar and Julia M. Comeau
In 2024, Novo Nordisk A/S was one of the most profitable firms in the world, thanks largely to just two GLP-1-based drugs, Ozempic and Wegovy. Unusually, this incredibly profitable firm was controlled not by individual private shareholders, but by a non-profit... View Details
Keywords: Pharmaceutical Companies; Diabetes; Obesity; Foundation; Non-profit Management; Profit; Corporate Governance; Business or Company Management; Corporate Social Responsibility and Impact; Expansion; Philanthropy and Charitable Giving; Nonprofit Organizations; Pharmaceutical Industry; Denmark; Europe
Spar, Debora L., and Julia M. Comeau. "Novo Nordisk Foundation." Harvard Business School Case 325-031, August 2024. (Revised February 2025.)
- August 2024
- Background Note